Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study - Concepedia

Concepedia

Publication | Closed Access

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

131

Citations

14

References

2011

Year

S. D. Cook, Patrick Vermersch, Gavin Giovannoni, Kottil Rammohan, Peter Rieckmann, Per Soelberg Sørensen, Anthony Hamlett, Montserrat Miret, Joseph Weiner, Vissia Viglietta,

Multiple Sclerosis Journal

Abstract

The safety and tolerability profile observed in the CLARITY study together with the reported efficacy support the potential for cladribine tablets as an MS therapy.

References

	Year	Citations

Page 1